{
  "items": "18",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "Precision Trading with Vicarious Surgical Inc. Class A (RBOT) Risk Zones",
      "url": "https://news.stocktradersdaily.com/news_release/23/Precision_Trading_with_Vicarious_Surgical_Inc._Class_A_RBOT_Risk_Zones_122525032002_1766650802.html",
      "time_published": "20251225T032000",
      "authors": [
        "William C.",
        "Thomas H. Kee Jr."
      ],
      "summary": "This article details precision trading strategies for Vicarious Surgical Inc. Class A (NASDAQ: RBOT) based on AI-generated signals. It outlines institutional trading strategies, including position trading, momentum breakout, and risk hedging, with placeholders for entry zones, targets, and stop losses. The analysis also provides multi-timeframe signal analysis, identifying support and resistance levels for the stock.",
      "banner_image": "https://news.stocktradersdaily.com/media/693596_RBOT_graph.jpg",
      "source": "Stock Traders Daily",
      "category_within_source": "General",
      "source_domain": "Stock Traders Daily",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "technology",
          "relevance_score": "0.847558"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.726709"
        }
      ],
      "overall_sentiment_score": 0.037133,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.049744",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Vicarious Surgical (NYSE: RBOT) warrants to be withdrawn from NYSE listing",
      "url": "https://www.stocktitan.net/sec-filings/RBOT/25-nse-vicarious-surgical-inc-sec-filing-f60a6d146a64.html",
      "time_published": "20251218T111046",
      "authors": [
        "NULL"
      ],
      "summary": "Vicarious Surgical Inc. (NYSE: RBOT) is delisting its warrants from the New York Stock Exchange, as detailed in an SEC Form 25 filing. The warrants, each exercisable for 1/30th of a Class A common stock share at $345.00, are being voluntarily withdrawn by the issuer in compliance with NYSE and SEC requirements. The filing was certified by the NYSE on December 17, 2025.",
      "banner_image": "NULL",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        }
      ],
      "overall_sentiment_score": 0.003763,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.009464",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Vicarious Surgical (RBOT) sets special meeting on 2.3M warrant share approval",
      "url": "https://www.stocktitan.net/sec-filings/RBOT/def-14a-vicarious-surgical-inc-definitive-proxy-statement-e35c83067df8.html",
      "time_published": "20251216T000915",
      "authors": [],
      "summary": "Vicarious Surgical has scheduled a special stockholder meeting for January 9, 2026, to vote on the exercise of Common Warrants for up to 2.3 million shares of Class A common stock at $5.10 per share. This approval is necessary under NYSE rules. If approved and fully exercised, the company could gain approximately $11.7 million in additional gross proceeds, but existing shareholders would face dilution.",
      "banner_image": "https://www.stocktitan.net/img/logo/stock-titan-logo-header-free.png",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "1.000000"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.924601"
        }
      ],
      "overall_sentiment_score": 0.135104,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.134777",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "How Vicarious Surgical Inc. Class A (RBOT) Affects Rotational Strategy Timing",
      "url": "https://news.stocktradersdaily.com/news_release/1/How_Vicarious_Surgical_Inc._Class_A_RBOT_Affects_Rotational_Strategy_Timing_121425012602_1765693562.html",
      "time_published": "20251214T012600",
      "authors": [
        "Thomas H. Kee Jr"
      ],
      "summary": "This article from Stock Traders Daily analyzes Vicarious Surgical Inc. Class A (RBOT) and its impact on rotational strategy timing. It details AI-generated trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The article aims to help investors understand how RBOT's signals can be integrated into different trading approaches for optimized risk management.",
      "banner_image": "https://news.stocktradersdaily.com/media/685638_RBOT_graph.jpg",
      "source": "Stock Traders Daily",
      "category_within_source": "General",
      "source_domain": "Stock Traders Daily",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.909307"
        },
        {
          "topic": "technology",
          "relevance_score": "0.619480"
        }
      ],
      "overall_sentiment_score": 0.007318,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.046101",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "[424B3] Vicarious Surgical Inc. Prospectus Filed Pursuant to Rule 424(b)(3)",
      "url": "https://www.stocktitan.net/sec-filings/RBOT/424b3-vicarious-surgical-inc-prospectus-filed-pursuant-to-rule-424-b--047f42a8fab9.html",
      "time_published": "20251208T111046",
      "authors": [],
      "summary": "Vicarious Surgical Inc. has filed a prospectus to register for resale up to 2,300,000 shares of Class A common stock stemming from Series A and Series B common warrants. The company will not receive proceeds from the resale of these shares but will benefit from cash exercises of the warrants. This filing highlights potential dilution and the ongoing development of their robotic surgical system, which has not yet received FDA authorization.",
      "banner_image": "https://www.sec.gov/Archives/edgar/data/0001812173/000121390025119678/image_001.jpg",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.947315"
        },
        {
          "topic": "finance",
          "relevance_score": "0.834111"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.720210"
        }
      ],
      "overall_sentiment_score": -0.113775,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "0.995114",
          "ticker_sentiment_score": "-0.149247",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Khalifa Sammy, Vicarious Surgical CTO, sells $709 in RBOT stock",
      "url": "https://www.investing.com/news/insider-trading-news/khalifa-sammy-vicarious-surgical-cto-sells-709-in-rbot-stock-93CH-4392421",
      "time_published": "20251205T043256",
      "authors": [
        "Investing.com"
      ],
      "summary": "Khalifa Sammy, CTO of Vicarious Surgical Inc. (NASDAQ:RBOT), sold 239 shares of Class A Common Stock for a total of $709 to cover tax withholding obligations. This transaction was part of the company's equity incentive plan, and following the sale, Sammy Khalifa directly owns 33,623 shares. Despite recent stock volatility, Vicarious Surgical is improving its financial outlook by reducing its projected 2025 cash burn and narrowing its net loss.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.849148"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.930674"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.731741"
        },
        {
          "topic": "technology",
          "relevance_score": "0.638235"
        }
      ],
      "overall_sentiment_score": -0.102086,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.126069",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Sachs Adam David, president at Vicarious Surgical, sells $1366 in stock",
      "url": "https://www.investing.com/news/insider-trading-news/sachs-adam-david-president-at-vicarious-surgical-sells-1366-in-stock-93CH-4392420",
      "time_published": "20251204T072900",
      "authors": [
        "Investing.com"
      ],
      "summary": "Adam David Sachs, President at Vicarious Surgical Inc. (NASDAQ:RBOT), sold 463 shares for a total of $1366 to cover tax withholding obligations related to restricted stock units. Despite the sale, Sachs directly owns 47,885 shares, and the company, with a market cap of $19.19 million, appears undervalued by InvestingPro. Vicarious Surgical is focused on cost efficiency, evidenced by reduced operating expenses and revised cash burn guidance for 2025.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.916714"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.809012"
        },
        {
          "topic": "finance",
          "relevance_score": "0.726130"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.610521"
        },
        {
          "topic": "technology",
          "relevance_score": "0.648844"
        }
      ],
      "overall_sentiment_score": 0.089412,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.080072",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Vicarious Surgical (NYSE: RBOT) Trims 2025 Cash Burn by $5M, Updates Board",
      "url": "https://www.stocktitan.net/news/RBOT/vicarious-surgical-announces-reduction-in-2025-cash-burn-bun1xzaryifs.html",
      "time_published": "20251203T070000",
      "authors": [
        "NULL"
      ],
      "summary": "Vicarious Surgical Inc. has updated its full-year 2025 financial guidance, reducing its expected cash burn to approximately $45 million, a $5 million improvement from previous guidance, due to disciplined cost management. The company also announced new committee appointments to its Board of Directors, with Victoria Carr-Brendel becoming Chair of the Compensation Committee, Fuad Ahmad joining the Compensation Committee, and Joseph Doherty joining the Audit Committee. Vicarious Surgical plans to provide 2026 cash burn guidance before year-end, reflecting further operational resets.",
      "banner_image": "NULL",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.941277"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.836493"
        },
        {
          "topic": "finance",
          "relevance_score": "0.708885"
        },
        {
          "topic": "technology",
          "relevance_score": "0.624638"
        }
      ],
      "overall_sentiment_score": 0.214919,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.248785",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Sachs Adam David, president at Vicarious Surgical, sells $2215 in stock",
      "url": "https://in.investing.com/news/insider-trading-news/sachs-adam-david-president-at-vicarious-surgical-sells-2215-in-stock-93CH-5122819",
      "time_published": "20251125T140951",
      "authors": [
        "Investing.com"
      ],
      "summary": "Adam David Sachs, President at Vicarious Surgical Inc. (NASDAQ:RBOT), sold 816 shares of Class A Common Stock for $2215 on November 20, 2025. This \"sell to cover\" transaction was mandated by the company's equity incentive plan to meet tax obligations related to restricted stock units and does not represent a discretionary trade. While the stock appears undervalued by InvestingPro metrics, the company faces significant financial health challenges, despite recent improvements in operating expenses and a smaller net loss reported in Q3 2025.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
      "source": "Investing.com India",
      "category_within_source": "General",
      "source_domain": "Investing.com India",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.914969"
        },
        {
          "topic": "finance",
          "relevance_score": "0.724087"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.838394"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.727270"
        }
      ],
      "overall_sentiment_score": -0.220243,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "0.998385",
          "ticker_sentiment_score": "-0.214432",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Sachs Adam David, president at Vicarious Surgical, sells $2215 in stock By Investing.com",
      "url": "https://za.investing.com/news/insider-trading-news/sachs-adam-david-president-at-vicarious-surgical-sells-2215-in-stock-93CH-3998164",
      "time_published": "20251124T043256",
      "authors": [
        "Investing.com"
      ],
      "summary": "Adam David Sachs, President at Vicarious Surgical Inc (NASDAQ:RBOT), sold 816 shares of Class A Common Stock for $2215 on November 20, 2025. This sale was a \"sell to cover\" transaction to meet tax withholding obligations related to restricted stock units and was not a discretionary trade. The company is noted to have a weak financial health score despite its stock appearing undervalued by InvestingPro metrics.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
      "source": "Investing.com South Africa",
      "category_within_source": "General",
      "source_domain": "Investing.com South Africa",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.948630"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.806528"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.747757"
        },
        {
          "topic": "finance",
          "relevance_score": "0.627163"
        }
      ],
      "overall_sentiment_score": 0.04831,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "0.332844",
          "ticker_sentiment_score": "0.014418",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Sachs Adam David, president at Vicarious Surgical, sells $2215 in stock",
      "url": "https://www.investing.com/news/insider-trading-news/sachs-adam-david-president-at-vicarious-surgical-sells-2215-in-stock-93CH-4374014",
      "time_published": "20251121T193600",
      "authors": [
        "Investing.com"
      ],
      "summary": "Adam David Sachs, President at Vicarious Surgical Inc (NASDAQ:RBOT), sold 816 shares of Class A Common Stock for a total of $2215 to cover tax withholding obligations related to the vesting of restricted stock units. This transaction was mandated by the company's equity incentive plan and does not represent a discretionary trade. Despite RBOT appearing undervalued, the company faces financial challenges, though it recently reported decreased operating expenses and a smaller net loss in Q3 2025.",
      "banner_image": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.819991"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.723868"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.638607"
        }
      ],
      "overall_sentiment_score": -0.391265,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.385711",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Vicarious Surgical Reports Third Quarter 2025 Financial Results",
      "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Business%20Wire/36082492/vicarious-surgical-reports-third-quarter-2025-financial-results/",
      "time_published": "20251112T151500",
      "authors": [
        "NULL"
      ],
      "summary": "Vicarious Surgical Inc. announced its third quarter 2025 financial results, highlighting a significant decrease in operating expenses and a narrower GAAP net loss compared to the previous year. CEO Stephen From emphasized progress in execution and capital discipline, including a $5.9 million registered direct offering in October. The company also provided a full-year 2025 cash burn guidance of approximately $50 million.",
      "banner_image": "https://barchart-news-media-prod.aws.barchart.com/BIZWIRE/efdfbe2cc65c3f00688f41aeaa5c95df/ct%3Fid%3Dbwnews%26amp%3Bsty%3D20251112785714r1%26amp%3Bsid%3Dchbar%26amp%3Bdistro%3Dftp",
      "source": "The Globe and Mail",
      "category_within_source": "General",
      "source_domain": "The Globe and Mail",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.908053"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.702446"
        },
        {
          "topic": "technology",
          "relevance_score": "0.642432"
        }
      ],
      "overall_sentiment_score": 0.265571,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.284820",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Vicarious Surgical raises $5.9M in direct and private placement offering; shares down",
      "url": "https://www.msn.com/en-us/money/companies/vicarious-surgical-raises-5-9m-in-direct-and-private-placement-offering-shares-down/ar-AA1O4urs?ocid=finance-verthp-feeds",
      "time_published": "20251009T130912",
      "authors": [
        "NULL"
      ],
      "summary": "Vicarious Surgical has successfully raised $5.9 million through a direct and private placement offering. Despite this capital injection, the company's shares experienced a decline. No further details about the offering or the reason for the share downturn were provided in the excerpt.",
      "banner_image": "NULL",
      "source": "MSN",
      "category_within_source": "General",
      "source_domain": "MSN",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.943187"
        }
      ],
      "overall_sentiment_score": -0.208098,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.242336",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Vicarious Surgical Announces Appointment of Joseph Doherty as Chairman of The Board",
      "url": "https://orthospinenews.com/2025/09/26/vicarious-surgical-announces-appointment-of-joseph-doherty-as-chairman-of-the-board/",
      "time_published": "20250926T043256",
      "authors": [
        "Tim Allen"
      ],
      "summary": "Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) has appointed Joseph Doherty as Chairman of its Board of Directors. Doherty brings extensive experience from the healthcare and medical device industries, including leadership roles at Scapa Healthcare, Olympus Surgical Technologies America, and Johnson & Johnson. He aims to drive the company's mission to transform robotic surgery and enhance patient outcomes.",
      "banner_image": "https://orthospinenews.com/wp-content/uploads/2025/03/31-hiwerevicarioussurgicala99-1.jpg",
      "source": "Ortho Spine News",
      "category_within_source": "General",
      "source_domain": "Ortho Spine News",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.935669"
        },
        {
          "topic": "finance",
          "relevance_score": "0.735077"
        }
      ],
      "overall_sentiment_score": 0.246284,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.334850",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "JNJ",
          "relevance_score": "0.608254",
          "ticker_sentiment_score": "0.148616",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Vicarious Surgical delays robot timeline",
      "url": "https://www.medtechdive.com/news/Vicarious-Surgical-delays-robot-timeline/757636/",
      "time_published": "20250813T100908",
      "authors": [
        "Susan Kelly"
      ],
      "summary": "Vicarious Surgical has announced a delay in its timeline for starting clinical trials for its surgical robot, with CEO Stephen From stating the company will focus on completing the commercial system's design instead. This decision has caused the company's shares to drop, and analysts suggest Vicarious Surgical may need non-dilutive financing to continue operations. The company aims to compete with Intuitive Surgical in the single-port robotic market for abdominal procedures.",
      "banner_image": "https://imgproxy.divecdn.com/Rfb1dtjXQuxuiOzpNB2XCWN95Cz-Uu-Ym_F4TaaW0k4/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9WaWNhcmlvdXNTdXJnaWNhbF9TeXN0ZW1fMDIucG5n.webp",
      "source": "MedTech Dive",
      "category_within_source": "General",
      "source_domain": "MedTech Dive",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.942530"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.819086"
        },
        {
          "topic": "technology",
          "relevance_score": "0.737893"
        }
      ],
      "overall_sentiment_score": -0.63361,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.630825",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Deliver On Growth Plans?",
      "url": "https://www.sahmcapital.com/news/content/is-vicarious-surgical-nyserbot-in-a-good-position-to-deliver-on-growth-plans-2025-03-18",
      "time_published": "20250318T043256",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Vicarious Surgical (NYSE:RBOT) is an unprofitable company with a cash burn of US$51m annually. Although it has reduced its cash burn by 29% year over year, its current cash runway is only about 14 months, and its cash burn is approximately equivalent to its market capitalization, raising concerns about its ability to raise additional funds. Shareholders should monitor the company's financial situation carefully.",
      "banner_image": "https://images.simplywall.st/asset/chart/317659974-debt-equity-history-analysis-1-dark/1742298656700",
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.838057"
        }
      ],
      "overall_sentiment_score": -0.221006,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.239934",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Vicarious Surgical Announces Launch of Proposed Public Offering",
      "url": "https://www.stocktitan.net/news/RBOT/vicarious-surgical-announces-launch-of-proposed-public-vxnp147m3um6.html",
      "time_published": "20230802T164500",
      "authors": [],
      "summary": "Vicarious Surgical Inc. announced the commencement of an underwritten public offering of $45.0 million of its Class A common stock, with an option for underwriters to purchase an additional $6.75 million. The company plans to use the net proceeds, along with existing cash, to fund ongoing operations, including the development of its single-port surgical robot, the Vicarious Surgical System, and for general corporate purposes. Morgan Stanley & Co. LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering.",
      "banner_image": null,
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "ipo",
          "relevance_score": "1.000000"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.933632"
        },
        {
          "topic": "finance",
          "relevance_score": "0.815365"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.730196"
        },
        {
          "topic": "technology",
          "relevance_score": "0.600433"
        }
      ],
      "overall_sentiment_score": 0.107459,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.112886",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Jeffrey Scott Obituary (1978 - 2022) - Foxborough, MA - Sun Chronicle",
      "url": "https://www.legacy.com/us/obituaries/thesunchronicle/name/jeffrey-scott-obituary?id=32283327",
      "time_published": "20220119T181656",
      "authors": [],
      "summary": "Jeffrey R. Scott, PhD, age 43 of Foxborough, passed away on Friday, January 14, 2022. He was a devoted husband and father, and had a significant career in the Medical Device industry, most recently as Director of Clinical Engineering at Vicarious Surgical, Inc., and also served as an Adjunct Professor at Brown University. The obituary details his life, career, family, and funeral arrangements, including a donation fund in his memory.",
      "banner_image": null,
      "source": "Legacy obituary",
      "category_within_source": "General",
      "source_domain": "Legacy obituary",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.738571"
        }
      ],
      "overall_sentiment_score": 0.135107,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "RBOT",
          "relevance_score": "0.929273",
          "ticker_sentiment_score": "0.137881",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    }
  ]
}